Elevance Health (ELV) Net Cash Flow (2010 - 2026)

Elevance Health (ELV) has 17 years of Net Cash Flow data on file, last reported at $175.0 million in Q1 2026.

• Quarterly Net Cash Flow rose 122.18% year-over-year to $175.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 billion (up 61.49% YoY) and the FY2025 annual result came in at $1.2 billion, down 34.13% from the prior year.
• Net Cash Flow slipped to $175.0 million in Q1 2026 per ELV's latest filing, from $784.0 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $2.8 billion in Q1 2023 and bottomed at -$4.4 billion in Q4 2023.
• The 5-year median for Net Cash Flow is $301.0 million (2022), against an average of $286.9 million.
• The widest annual swing landed in 2022, when Net Cash Flow surged 935.04%; it then plunged 195.49% in 2023.
• Tracing ELV's Net Cash Flow over 5 years: stood at -$1.5 billion in 2022, then sank by 195.49% to -$4.4 billion in 2023, then surged by 110.83% to $476.0 million in 2024, then surged by 64.71% to $784.0 million in 2025, then plunged by 77.68% to $175.0 million in 2026.
• Per Business Quant, the three latest ELV Net Cash Flow figures stand at $175.0 million (Q1 2026), $784.0 million (Q4 2025), and $154.0 million (Q3 2025).

Peer Comparison